ProfileGDS5822 / ILMN_2589819
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 97% 95% 96% 96% 96% 96% 96% 96% 96% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 11756.897
GSM1276600PDAC Late Ablation Control 21184.295
GSM1276601PDAC Late Ablation Control 31661.496
GSM1276602PDAC Late Ablation 1146596
GSM1276603PDAC Late Ablation 21473.496
GSM1276604PDAC Late Ablation 31983.296
GSM1303940PDAC Late Ablation_anti-CTLA4 11415.796
GSM1303941PDAC Late Ablation_anti-CTLA4 21642.596
GSM1303942PDAC Late Ablation_anti-CTLA4 31909.196